Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257–265

Diabetes Care 2026

View at publisher

Authors: S B Li

DOI: 10.2337/dc26-0265

Cited by: 1

References: 3

Fields of Study & Subjects

Diabetes Treatment and Management Chronic Kidney Disease and Diabetes Diabetes Cardiovascular Risks and Lipoproteins

References 3